SPLEEN ATROPHY

This adverse event was reported 59 times

These drugs are most commonly taken by patients reporting SPLEEN ATROPHY:

# Drug Count
0 IBRUTINIB 13
1 VENETOCLAX 13
2 RITUXIMAB 12
3 ACALABRUTINIB 10
4 BENDAMUSTINE HCL 9
5 PREDNISOLONE 8
6 PREDNISOLONE ORAL 8
7 PREDNISOLONE ORAL SOLUTION 8
8 PANTOPRAZOLE 7
9 RUXOLITINIB 7
See all common drugs associated with SPLEEN ATROPHY

SPLEEN ATROPHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TALIGLUCERASE ALFA 1 0.0017
1 ACALABRUTINIB 10 0.0008
2 PACRITINIB 2 0.0007
3 BENDAMUSTINE HCL 9 0.0006
4 MILK THISTLE 1 0.0005
5 INSTALAX POLYETHYLENE GLYCOL 3350 4 0.0003
6 POLYETHYLENE GLYCOL 400 4 0.0003
7 AMOXICILLIN AND CLAVULANATE POTASSIUM 1 0.0002
8 VENETOCLAX 13 0.0002
9 BECLOMETHASONE DIPROPIONATE 1 0.0002
See all drugs enriched for association with SPLEEN ATROPHY

SPLEEN ATROPHY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 beta Lactamase Inhibitor [EPC] 1 0.0002
1 BCL-2 Inhibitor [EPC] 13 0.0002
2 Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] 1 0.0001
3 Antimalarial [EPC] 1 0.0001
4 Antiprotozoal [EPC] 1 0.0001
5 Janus Kinase Inhibitor [EPC] 8 0.0000
6 Pyridone [EPC] 2 0.0000
7 Kinase Inhibitor [EPC] 26 0.0000
8 CD20-directed Cytolytic Antibody [EPC] 12 0.0000
9 Iron Chelator [EPC] 1 0.0000
See all drug classes enriched for association with SPLEEN ATROPHY